Skip to Main Content

Author Details

Lisa Miorin
Icahn School of Medicine at Mount Sinai
2008
48
27
Andrej Sali (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
34845443Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single cell RNA sequencing.bioRxiv2023
37738983Impact of SARS-CoV-2 ORF6 and its variant polymorphisms on host responses and viral pathogenesis.Cell Host Microbe2023
37738970SARS-CoV-2 variants evolve convergent strategies to remodel the host response.Cell2023
37676044Unambiguous detection of SARS-CoV-2 subgenomic mRNAs with single-cell RNA sequencing.Microbiol Spectr2023
36523164SARS-CoV-2 viral protein ORF3A injures renal tubules by interacting with TRIM59 to induce STAT3 activation.Mol Ther2023
34669512Functional Effects of Cardiomyocyte Injury in COVID-19.J Virol2022
36519174Interaction between chicken TRIM25 and MDA5 and their role in mediated antiviral activity against IBDV infection.Front Microbiol2022
36112363Autoantibodies against type I IFNs in patients with critical influenza pneumonia.J Exp Med2022
36044897Discovery and intranasal administration of a SARS-CoV-2 broadly acting neutralizing antibody with activity against multiple Omicron subvariants.Med2022
35271801SLiMs go viral! One more weapon against interferon.Cell Host Microbe2022
35169796The oral drug nitazoxanide restricts SARS-CoV-2 infection and attenuates disease pathogenesis in Syrian hamsters.bioRxiv2022
33440148MDA5 Governs the Innate Immune Response to SARS-CoV-2 in Lung Epithelial Cells.Cell Rep2021
33795830Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.Mod Pathol2021
33495306Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A.Science2021
33547084Nsp1 protein of SARS-CoV-2 disrupts the mRNA export machinery to inhibit host gene expression.Sci Adv2021
33930332Functional landscape of SARS-CoV-2 cellular restriction.Mol Cell2021
33501468The N501Y mutation in SARS-CoV-2 spike leads to morbidity in obese and aged mice and is neutralized by convalescent and post-vaccination human sera.medRxiv2021
34512601African Swine Fever Virus Induces STAT1 and STAT2 Degradation to Counteract IFN-I Signaling.Front Microbiol2021
34593848The virucidal effects of 405 nm visible light on SARS-CoV-2 and influenza A virus.Sci Rep2021
34161170Control of Innate Immune Activation by Severe Acute Respiratory Syndrome Coronavirus 2 and Other Coronaviruses.J Interferon Cytokine Res2021
33961839Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.Hum Pathol2021
33984267Hepatitis C virus drugs that inhibit SARS-CoV-2 papain-like protease synergize with remdesivir to suppress viral replication in cell culture.Cell Rep2021
33317424A household case evidences shorter shedding of SARS-CoV-2 in naturally infected cats compared to their human owners.Emerg Microbes Infect2021
32511357A Large-scale Drug Repositioning Survey for SARS-CoV-2 Antivirals.bioRxiv2020
33200140Physiology of cardiomyocyte injury in COVID-19.medRxiv2020
33060197Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.Science2020
33024967Functional Landscape of SARS-CoV-2 Cellular Restriction.bioRxiv2020
33097660SARS-CoV-2 Orf6 hijacks Nup98 to block STAT nuclear import and antagonize interferon signaling.Proc Natl Acad Sci U S A2020
32707573Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.Nature2020
32645325The Global Phosphorylation Landscape of SARS-CoV-2 Infection.Cell2020
32585083An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.Curr Protoc Microbiol2020
32353859A SARS-CoV-2 protein interaction map reveals targets for drug repurposing.Nature2020
32398876A serological assay to detect SARS-CoV-2 seroconversion in humans.Nat Med2020
32511441A serological assay to detect SARS-CoV-2 seroconversion in humans.medRxiv2020
31043530Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.J Virol2019
31603272Virus-induced autophagic degradation of STAT2 as a mechanism for interferon signaling blockade.EMBO Rep2019
28679761The Host E3-Ubiquitin Ligase TRIM6 Ubiquitinates the Ebola Virus VP35 Protein and Promotes Virus Replication.J Virol2017
28576494Antagonism of type I interferon by flaviviruses.Biochem Biophys Res Commun2017
27212660Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.Cell Host Microbe2016
26542763Visual detection of Flavivirus RNA in living cells.Methods2016
24882218Unanchored K48-linked polyubiquitin synthesized by the E3-ubiquitin ligase TRIM6 stimulates the interferon-IKKε kinase-mediated antiviral response.Immunity2014
25211074The interferon signaling antagonist function of yellow fever virus NS5 protein is activated by type I interferon.Cell Host Microbe2014
25078692A single amino acid substitution in the novel H7N9 influenza A virus NS1 protein increases CPSF30 binding and virulence.J Virol2014
24760882Tumor suppressor cylindromatosis (CYLD) controls HIV transcription in an NF-κB-dependent manner.J Virol2014
23552408Three-dimensional architecture of tick-borne encephalitis virus replication sites and trafficking of the replicated RNA.J Virol2013
22155022Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling.Virus Res2012
18667221Spatial and temporal organization of tick-borne encephalitis flavivirus replicated RNA in living cells.Virology2008
18533218Analysis of the effects of alterations in the tick-borne encephalitis virus 3'-noncoding region on translation and RNA replication using reporter replicons.Virology2008
  • 1 - 48 of 48

Recommended Authors

Aminu S Jahun
University of Cambridge, Addenbrooke's Hospital Level 5
Career Start Year 2017
Number of shared co-authors 28
Adam Hage
University of Texas Medical Branch
Career Start Year 2017
Number of shared co-authors 11
Andreas S Puschnik
Stanford University School of Medicine
Career Start Year 2013
Number of shared co-authors 17
David Sachs
Icahn School of Medicine at Mount Sinai
Career Start Year 2013
Number of shared co-authors 23
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 6
Craig B Wilen
Yale School of Medicine
Career Start Year 2010
Number of shared co-authors 7
Siyuan Ding
Washington University School of Medicine
Career Start Year 2009
Number of shared co-authors 6
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 4
Holly Ramage
Sidney Kimmel Medical College, Thomas Jefferson University
Career Start Year 2009
Number of shared co-authors 7
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 4
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 11
Mohsan Saeed
Boston University Chobanian and Avedisian School of Medicine
Career Start Year 2007
Number of shared co-authors 2
Nicholas S Heaton
Duke University School of Medicine
Career Start Year 2006
Number of shared co-authors 21
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 1
Courtney Wilkins
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2005
Number of shared co-authors 1
Yaw Shin Ooi
Duke-NUS Medical School
Career Start Year 2003
Number of shared co-authors 5
Alexandra Sch??fer
University of North Carolina at Chapel Hill
Career Start Year 2003
Number of shared co-authors 4
Shirit Einav
Stanford University School of Medicine
Career Start Year 2002
Number of shared co-authors 4
Priya S Shah
University of California davis
Career Start Year 2002
Number of shared co-authors 21
Gaya K Amarasinghe
Washington University School of Medicine at St. Louis
Career Start Year 2000
Number of shared co-authors 9
Victor R DeFilippis
Vaccine and Gene Therapy Institute, Oregon Health and Science University
Career Start Year 2000
Number of shared co-authors 1
Daisy W Leung
Washington University School of Medicine
Career Start Year 1999
Number of shared co-authors 10
Amy C Sims
The University of North Carolina at Chapel Hill
Career Start Year 1998
Number of shared co-authors 1
Pei-Yong Shi
University of Texas Medical Branch
Career Start Year 1996
Number of shared co-authors 18
Abraham L Brass
University of Massachusetts Medical School
Career Start Year 1995
Number of shared co-authors 15
Sara Cherry
University of Pennsylvania
Career Start Year 1993
Number of shared co-authors 15
Lucy Thorne
University College London
Career Start Year 1992
Number of shared co-authors 32
Michael Gale
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 1988
Number of shared co-authors 8
Michael S Diamond
Washington University School of Medicine
Career Start Year 1982
Number of shared co-authors 28
Ralph S Baric
University of North Carolina
Career Start Year 1981
Number of shared co-authors 14

Collaborators

Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 38
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 13
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 8
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 8
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Sumit K Chanda
The Scripps Research Institute
Co-authored papers 7
Laura Martin-Sancho
The Scripps Research Institute
Co-authored papers 6
Mehdi Bouhaddou
J. David Gladstone Institutes
Co-authored papers 6
Randy A Albrecht
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Paul D De Jesus
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 5
Lars Pache
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 5
Yuan Pu
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 5
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers 5
Danielle L Swaney
J. David Gladstone Institutes
Co-authored papers 5
Margaret Soucheray
J. David Gladstone Institutes
Co-authored papers 5
Kirsten Obernier (CM4AI)
University of California San Francisco
Co-authored papers 5
Jyoti Batra
J. David Gladstone Institutes
Co-authored papers 5
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Xin Yin
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 5
Jiewei Xu
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 4
Brad R Rosenberg
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Soner Yildiz
University of Geneva
Co-authored papers 4
Marco Vignuzzi
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 4
Ruth H??ttenhain
Quantitative Biosciences Institute (QBI), University of California san francisco
Co-authored papers 4
Kevan M Shokat
University of California San Francisco
Co-authored papers 4
Carles Mart??nez-Romero
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Phillip Cohen
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Thomas P Zwaka
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Release 1.2